Department of Ophthalmology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
Department of Ophthalmology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
Med Clin North Am. 2021 May;105(3):493-510. doi: 10.1016/j.mcna.2021.01.004. Epub 2021 Apr 2.
Glaucoma is the leading cause of irreversible blindness worldwide. The global prevalence of glaucoma in people aged 40 to 80 years is estimated to be 3.5%. With the growing number and proportion of older persons in the population, it is projected that 111.8 million people will have glaucoma in 2040. Currently available treatments cannot reverse glaucomatous damage to the visual system; however, early diagnosis and treatment can prevent progression of the disease. In most cases, glaucoma is a chronic condition that requires lifelong management. This article reviews the pathophysiology, classification, clinical manifestations, diagnosis, and management of glaucoma.
青光眼是全球范围内导致不可逆性失明的主要原因。估计全球 40 岁至 80 岁人群中青光眼的患病率为 3.5%。随着人口中老年人口数量和比例的增加,预计 2040 年将有 1.118 亿人患有青光眼。目前可利用的治疗方法无法逆转视觉系统的青光眼损伤;然而,早期诊断和治疗可以阻止疾病的进展。在大多数情况下,青光眼是一种慢性疾病,需要终身管理。本文综述了青光眼的病理生理学、分类、临床表现、诊断和管理。